AR029618A1 - Compuestos de amida , procedimientos para prepararlos, las composiciones farmaceuticas que los contienen y el uso de dichos compuestos para la fabricacion de medicamentos - Google Patents
Compuestos de amida , procedimientos para prepararlos, las composiciones farmaceuticas que los contienen y el uso de dichos compuestos para la fabricacion de medicamentosInfo
- Publication number
- AR029618A1 AR029618A1 ARP000100793A ARP000100793A AR029618A1 AR 029618 A1 AR029618 A1 AR 029618A1 AR P000100793 A ARP000100793 A AR P000100793A AR P000100793 A ARP000100793 A AR P000100793A AR 029618 A1 AR029618 A1 AR 029618A1
- Authority
- AR
- Argentina
- Prior art keywords
- compounds
- pharmaceutical compositions
- compositions containing
- medicines
- procedures
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 5
- 239000003814 drug Substances 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 241000670727 Amida Species 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- -1 Amide compounds Chemical class 0.000 abstract 1
- 208000000044 Amnesia Diseases 0.000 abstract 1
- 208000031091 Amnestic disease Diseases 0.000 abstract 1
- 206010012289 Dementia Diseases 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 230000006986 amnesia Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/65—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/30—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPP8912A AUPP891299A0 (en) | 1999-02-26 | 1999-02-26 | New 6-membered cyclic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR029618A1 true AR029618A1 (es) | 2003-07-10 |
Family
ID=3813111
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP000100793A AR029618A1 (es) | 1999-02-26 | 2000-02-24 | Compuestos de amida , procedimientos para prepararlos, las composiciones farmaceuticas que los contienen y el uso de dichos compuestos para la fabricacion de medicamentos |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP1159258B1 (https=) |
| JP (1) | JP4089159B2 (https=) |
| KR (1) | KR100620406B1 (https=) |
| CN (1) | CN1170814C (https=) |
| AR (1) | AR029618A1 (https=) |
| AT (1) | ATE282022T1 (https=) |
| AU (2) | AUPP891299A0 (https=) |
| BR (1) | BR0010225A (https=) |
| CA (1) | CA2371827C (https=) |
| DE (1) | DE60015732T2 (https=) |
| DK (1) | DK1159258T3 (https=) |
| ES (1) | ES2226775T3 (https=) |
| HK (1) | HK1044934B (https=) |
| HU (1) | HUP0200116A3 (https=) |
| PT (1) | PT1159258E (https=) |
| RU (1) | RU2211215C2 (https=) |
| TR (1) | TR200102494T2 (https=) |
| TW (1) | TWI225856B (https=) |
| WO (1) | WO2000051970A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000030446A1 (en) | 1998-11-23 | 2000-06-02 | Bonnie Davis | Dosage formulations for acetylcholinesterase inhibitors |
| EE04996B1 (et) | 1998-12-24 | 2008-04-15 | Janssen Pharmaceutica N.V. | Reguleeritud vabanemisega galantamiinipreparaat, meetod selle valmistamiseks, seda sisaldav doseerimisvorm ning farmatseutiline pakend |
| TWI243164B (en) | 2001-02-13 | 2005-11-11 | Aventis Pharma Gmbh | Acylated indanyl amines and their use as pharmaceuticals |
| PE20020870A1 (es) | 2001-02-13 | 2002-11-18 | Aventis Pharma Gmbh | 6,7,8,9-tetrahidro-5h-benzocicloheptenil aminas aciladas |
| TWI241190B (en) * | 2001-02-13 | 2005-10-11 | Aventis Pharma Gmbh | 4-Fluoro-N-indan-2-yl benzamide and its use as pharmaceutical |
| PE20020856A1 (es) * | 2001-02-13 | 2002-11-11 | Aventis Pharma Gmbh | 1,2,3,4-tetrahidronaftil aminas aciladas |
| WO2003097586A1 (en) * | 2002-05-17 | 2003-11-27 | Janssen Pharmaceutica N.V. | Aminotetralin-derived urea modulators of vanilloid vr1 receptor |
| BRPI0413347A (pt) | 2003-08-06 | 2006-10-10 | Senomyx Inc | novos sabores, modificadores de sabor, agentes de sabor, realçadores de sabor, agentes de sabor e/ou realçadores umami ou doces, e utilização correspondente |
| KR101387563B1 (ko) | 2006-04-21 | 2014-04-25 | 세노믹스, 인코포레이티드 | 고효능의 조미용 향료를 포함하는 식품 조성물 및 이의 제조 방법 |
| EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| UY32442A (es) | 2009-02-13 | 2010-09-30 | Sanofi Aventis | Nuevos indanos sustituidos, procesos para su preparacion y uso de los mismos como un medicamento |
| JP2025066196A (ja) * | 2022-03-14 | 2025-04-23 | 国立大学法人東北大学 | 認知機能改善剤 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR8287M (https=) * | 1968-12-31 | 1970-11-09 | ||
| US4797419A (en) * | 1986-11-03 | 1989-01-10 | Warner-Lambert Company | Method of treating the symptoms of senile cognitive decline employing di- or trisubstituted urea cholinergic agents |
| EP0306375A1 (fr) * | 1987-08-07 | 1989-03-08 | Synthelabo | Dérivés de[(pipéridinyl-4)méthyl]-2 tétrahydro-1,2,3,4 isoquinoléine, leur préparation et leur application en thérapeutique |
| IL90279A (en) * | 1988-05-24 | 1995-03-30 | American Home Prod | Piperazinyl carboxamide derivatives, their preparation and pharmaceutical com¦ositions containing them |
| GB8917687D0 (en) * | 1989-08-02 | 1989-09-20 | Fujisawa Pharmaceutical Co | Aminopiperazine derivatives,processes for preparation thereof and pharmaceutical composition comprising the same |
| RU2024507C1 (ru) * | 1991-11-18 | 1994-12-15 | Евгений Яковлевич Левитин | 5-хлор-2-пиридиламид-4-нитро-n-(карбоксиметил)антраниловой кислоты, проявляющий противовоспалительную активность |
| JPH06107544A (ja) * | 1992-09-29 | 1994-04-19 | Taisho Pharmaceut Co Ltd | コリン作動性神経不全の改善・治療薬 |
| JPH06298732A (ja) * | 1993-02-16 | 1994-10-25 | Taisho Pharmaceut Co Ltd | インドール誘導体 |
-
1999
- 1999-02-26 AU AUPP8912A patent/AUPP891299A0/en not_active Abandoned
-
2000
- 2000-02-03 AU AU23257/00A patent/AU766655B2/en not_active Ceased
- 2000-02-03 KR KR1020017010325A patent/KR100620406B1/ko not_active Expired - Fee Related
- 2000-02-03 PT PT00902080T patent/PT1159258E/pt unknown
- 2000-02-03 RU RU2001126120/04A patent/RU2211215C2/ru not_active IP Right Cessation
- 2000-02-03 HU HU0200116A patent/HUP0200116A3/hu unknown
- 2000-02-03 BR BR0010225-3A patent/BR0010225A/pt not_active Application Discontinuation
- 2000-02-03 DE DE60015732T patent/DE60015732T2/de not_active Expired - Lifetime
- 2000-02-03 CN CNB008043035A patent/CN1170814C/zh not_active Expired - Fee Related
- 2000-02-03 DK DK00902080T patent/DK1159258T3/da active
- 2000-02-03 AT AT00902080T patent/ATE282022T1/de not_active IP Right Cessation
- 2000-02-03 EP EP00902080A patent/EP1159258B1/en not_active Expired - Lifetime
- 2000-02-03 JP JP2000602198A patent/JP4089159B2/ja not_active Expired - Fee Related
- 2000-02-03 CA CA002371827A patent/CA2371827C/en not_active Expired - Fee Related
- 2000-02-03 HK HK02106646.3A patent/HK1044934B/zh not_active IP Right Cessation
- 2000-02-03 WO PCT/JP2000/000601 patent/WO2000051970A1/en not_active Ceased
- 2000-02-03 ES ES00902080T patent/ES2226775T3/es not_active Expired - Lifetime
- 2000-02-03 TR TR2001/02494T patent/TR200102494T2/xx unknown
- 2000-02-14 TW TW089102410A patent/TWI225856B/zh not_active IP Right Cessation
- 2000-02-24 AR ARP000100793A patent/AR029618A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1159258A1 (en) | 2001-12-05 |
| BR0010225A (pt) | 2002-01-22 |
| JP4089159B2 (ja) | 2008-05-28 |
| CN1341095A (zh) | 2002-03-20 |
| ES2226775T3 (es) | 2005-04-01 |
| HK1044934B (zh) | 2005-06-03 |
| RU2211215C2 (ru) | 2003-08-27 |
| TWI225856B (en) | 2005-01-01 |
| DE60015732T2 (de) | 2005-03-31 |
| EP1159258B1 (en) | 2004-11-10 |
| PT1159258E (pt) | 2005-02-28 |
| CA2371827C (en) | 2008-06-10 |
| TR200102494T2 (tr) | 2002-01-21 |
| AUPP891299A0 (en) | 1999-03-25 |
| HK1044934A1 (en) | 2002-11-08 |
| DE60015732D1 (de) | 2004-12-16 |
| CN1170814C (zh) | 2004-10-13 |
| AU766655B2 (en) | 2003-10-23 |
| HUP0200116A3 (en) | 2002-11-28 |
| WO2000051970A1 (en) | 2000-09-08 |
| CA2371827A1 (en) | 2000-09-08 |
| KR100620406B1 (ko) | 2006-09-13 |
| AU2325700A (en) | 2000-09-21 |
| HUP0200116A2 (hu) | 2002-05-29 |
| DK1159258T3 (da) | 2005-02-14 |
| KR20010102140A (ko) | 2001-11-15 |
| ATE282022T1 (de) | 2004-11-15 |
| JP2002538132A (ja) | 2002-11-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR017182A1 (es) | Compuestos de aminotiazol, inhibidores de las kinasas dependientes de ciclinas y las composiciones farmaceuticas que los contienen. | |
| HU895609D0 (en) | Process for the preparation of novel 1,4-diazepine derivatives and pharmaceutical compositions containing such compounds | |
| NO905572L (no) | Fremgangsmaate for fremstilling av peptidforbindelser. | |
| ES2058527T3 (es) | Derivados de pirimidina condensados procedimiento y compuestos intermedios para su preparacion y composiciones farmaceuticas que los contienen. | |
| HUT55401A (en) | Process for producing platinum(ii) complexes and pharmaceutical compositions comprising such compounds as active ingredient | |
| ES2055860T3 (es) | Derivados 2-aminopirimidinona. | |
| AR018634A1 (es) | Derivados de benzo(b)tiepin-1,1,-dioxido, procedimiento para su preparacion, medicamentos conteniendo estos compuestos, procedimiento para la preparacion de medicamentos y su empleo para la preparacion de medicamentos. | |
| BR9908764A (pt) | Composto e seus sais farmaceuticamente aceitáveis ou ésteres hidrolisáveis in vivo, uso destes, processo para prepará-los, e, composição farmacêutica | |
| AR029383A1 (es) | Moleculas pequenas, los intermediarios para su sintesis, las composiciones farmaceuticas que las contienen y su uso para preparar un medicamento destinado al tratamiento o la profilaxis de enfermedades inflamatorias o mediadas por celulas inmunes | |
| MX9300498A (es) | Derivados de n-sulfonil-2-oxo-indol, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
| ATE103812T1 (de) | Zusammensetzung zur behandlung von ischaemischen stoerungen in organen. | |
| ES2123039T3 (es) | Nuevas 3-(hidroxi-bencilidenil)-indolin-2-onas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen. | |
| AR029618A1 (es) | Compuestos de amida , procedimientos para prepararlos, las composiciones farmaceuticas que los contienen y el uso de dichos compuestos para la fabricacion de medicamentos | |
| MY129176A (en) | Tetrahydro gamma-carbolines | |
| DE69311118D1 (de) | Phosphono-arylethanolamin-verbindungen mit antihyperglykämischer und/oder antiobeser wirkung | |
| NO892295D0 (no) | Fremgangsmaate for fremstilling av nye cefemforbindelser. | |
| DE3882679D1 (de) | Kardiovaskulaer aktive verbindungen. | |
| ES2153019T3 (es) | Derivados de benzo-dioxano, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| ES2094324T3 (es) | Nuevos derivados de pirrolidina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| MX9306394A (es) | Derivados de benzofurano, proceso para su preparacion y composicion farmaceutica que los contiene | |
| EA200101204A1 (ru) | Новые бициклические соединения аминопиразинона, способ их получения и содержащие их фармацевтические композиции | |
| UA50722C2 (uk) | Нітробензаміди, спосіб їх одержання (варіанти), фармацевтична композиція | |
| NO905245D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser. | |
| IT1216104B (it) | Peptidi ad attivita' farmaceutica. | |
| FI903511A0 (fi) | Pyrrolo (2,1-b) tiazolderivat. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |